|Articles|January 13, 2020
Ergomed Acquires Ashfield Pharmacovigilance Inc.
Advertisement
Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million.
For more information, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5